The net clinical benefit of targeted agents in the upfront treatment of elderly/unfit chronic lymphocytic leukemia patients: Results of network meta-analysis
(2023)
Journal Article
Molica, S., Allsup, D., Polliack, A., & Giannarelli, D. (2023). The net clinical benefit of targeted agents in the upfront treatment of elderly/unfit chronic lymphocytic leukemia patients: Results of network meta-analysis. European Journal of Haematology, 110(6), 774-777. https://doi.org/10.1111/ejh.13943
All Outputs (2)
Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age- and sex-matched population (2023)
Journal Article
Molica, S., Shanafelt, T. D., Allsup, D., & Giannarelli, D. (2023). Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age- and sex-matched population. American Journal of Hematology, https://doi.org/10.1002/ajh.27182